N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer

BACKGROUND: With a lack of specific symptoms, ovarian cancer (OV) is often diagnosed at an advanced stage. This coupled with inadequate prognostic indicators and treatments with limited therapeutic effect make OV the deadliest type of gynecological tumor. Recent research indicates that N6-methyladen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Xin, Tan, Jichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933961/
https://www.ncbi.nlm.nih.gov/pubmed/35303965
http://dx.doi.org/10.1186/s41065-022-00222-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933961/
https://www.ncbi.nlm.nih.gov/pubmed/35303965
http://dx.doi.org/10.1186/s41065-022-00222-3

Ejemplares similares